Embedded Files
NACinCOVID1 clinical trial at CHA has concluded enrollment; support NACinCOVID2 with a donation
Research into use of N-acetylcysteine as adjuvant therapy in treatment of SARS-CoV-2
N-Acetylcysteine to Combat COVID-19: An Evidence Review Therapeutics and Clinical Risk Management, November 2, 2020
N-Acetylcysteine to Combat COVID-19: An Evidence Review Therapeutics and Clinical Risk Management, November 2, 2020
Page updated
Google Sites
Report abuse